OPTIMIZED METHOD FOR THE TREATMENT OF CHRONIC HEADACHES
Keywords:
Chronic headache, migraine, VAS, CPAQ-R, HADS, SF-36, cognitive therapy, quality of life, psychotherapy, pharmacotherapy, cognitive functionAbstract
This article analyzes optimized methods for the effective treatment and prevention of chronic headaches, including various types of migraines. The study utilized standardized tools such as the Visual Analogue Scale (VAS), Migraine Disability Assessment Test (MIDAS), Headache Impact Test (HIT-6), Short Form Health Survey (SF-36), HADS, and CPAQ-R. Results showed that the treatment process significantly reduced pain intensity, improved psychological stability, enhanced quality of life, and led to improvements in cognitive function. Notably, a comprehensive approach combining cognitive-behavioral therapy, antidepressants, and anxiolytics proved effective. The study highlights the importance of an individualized and integrative approach to managing chronic headaches.
References
Bigal M.E., Liberman J.N., Lipton R.B. "Age-dependent prevalence and clinical features of migraine" // Neurology. 2006. Vol. 67, No.
P. 246–251.
Kosinski M., Bayliss M.S., Bjorner J.B., Ware J.E. Jr., Garber W.H., Batenhorst A., Cady R., Dahlöf C.G., Dowson A., Tepper S. "A six- item short-form survey for measuring headache impact: the HIT-6" // Quality of Life Research. 2003. Vol. 12, No. 8. P. 963–974. Ware J.E. Jr., Sherbourne C.D. "The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection" // Medical Care. 1992. Vol. 30, No. 6. P. 473–483.
Lantéri-Minet M., Duru G., Mudge M., Cottrell S. "Quality of life impairment, disability and economic burden associated with chronic migraine in France: a national survey" // Headache. 2011. Vol. 51, No. 5. P. 691–700.
Leonardi M., Raggi A. "Burden of migraine: international perspectives" // Neurological Sciences. 2013. Vol. 34, Suppl. 1. P. S117–S118.
Lipton R.B., Stewart W.F., Diamond S., Diamond M.L., Reed M. "Prevalence and burden of migraine in the United States: data from the American Migraine Study II" // Headache. 2001. Vol. 41, No. 7. P. 646–657.
Stewart W.F., Lipton R.B., Kolodner K., Sawyer J., Lee C., Liberman J.N. "Validity of the Migraine Disability Assessment (MIDAS) score in comparison to a diary-based measure in a population sample of migraine sufferers" // Pain. 2000. Vol. 88, No. 1. P. 41–52. ScienceDirect+1PubMed+1
Vos T., Flaxman A.D., Naghavi M., Lozano R., Michaud C., Ezzati M., Shibuya K., Salomon J.A., Abdalla S., Aboyans V., et al. "Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010" // The Lancet. 2012. Vol. 380, No. 9859. P. 2163–2196.
Wang S.J., Fuh J.L., Lu S.R., Juang K.D., Wang P.H. "Quality of life differs among headache diagnoses: analysis of SF-36 in a headache clinic" // Headache. 2001. Vol. 41, No. 1. P. 26–32. Buse D.C., Manack A.N., Fanning K.M., Serrano D., Reed M.L., Turkel C.C., Lipton R.B. "Chronic migraine prevalence, disability, and sociodemographic factors: results from the American Migraine Prevalence and Prevention Study" // Headache. 2012. Vol. 52, No. 10. P. 1456–1470.
Khaydarova Dildora Kadirovna, Khodjyeva Dilbar Tadjiyevna, Bobokulov Gulmurod Dilmurodovich. Optimization Of Neuroprotective Therapy Of Ischemic Stroke In The Acute Period. European Journal of Molecular & Clinical Medicine. Volume 07, Issue 03, 2020. Р. 3720-3723
Khodjieva D. T., Khaydarova D. K., Khaydarov N. K. Magnetic Resonance Imaging of Cerebral Hemorrhagic Stroke. International Journal of Psychosocial Rehabilitation, Vol. 24, 2020. Р 434-438.
Khaydarova D.K., Mansurova N.A. Analysis of Motor Complications in Parkinson’s Disease Phenotypes. Journal of Advances in Medicine and Medical Research. 25(5): 1-7, 2018;
